Adverse event in IPS cell (ips細胞) trial for vision loss in Japan: initial perspectives
Mandai, et al. NEJM 2017 Figure 1C
A team of researchers at RIKEN and Kobe City Medical Center reported at a press conference today a serious adverse event in a clinical trial participant receiving an induced pluripotent stem cell (IPS cell)-based therapy for vision loss.
According to Japan Times and Yahoo! Japan(in Japanese), the patient in question in the IPS cell trial for macular degeneration…
View On WordPress














